NIH Funding Opportunities
Request for Information (RFI): Input on NIAID Data Sharing Repository, Immunology Database and Analysis Portal (ImmPort), and Services
Notice NOT-AI-15-045 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 09:59:46 EST
Request for Proposals (RFP) Announcement: Comprehensive Resources for HIV Microbicides and Biomedical Prevention
Notice NOT-AI-15-047 from the NIH Guide for Grants and Contracts
Thu, 02 Jul 2015 01:45:26 EST
NCCIH Policy on Support of Clinical Trials in Ruth L. Kirschstein Research Awards for Predoctoral, Postdoctoral Fellows, Institutional, and Short-term Institutional Research Training
Notice NOT-AT-15-008 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 09:20:27 EST
Notice of National Center for Complementary and Integrative Health (NCCIH) Participation in PAR-15-085 "Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01)"
Notice NOT-AT-15-009 from the NIH Guide for Grants and Contracts
Thu, 02 Jul 2015 01:51:15 EST
Notice of Change in Application Review Cycle Frequency for the Superfund Hazardous Substance Basic Research and Training Program (P42)
Notice NOT-ES-15-018 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 10:34:54 EST
Notice of Change in Types of Applications Allowed for PAR-13-324 "Limited Pilot for NIGMS Legacy Community-Wide Scientific Resources (R24)"
Notice NOT-GM-15-119 from the NIH Guide for Grants and Contracts
Mon, 29 Jun 2015 01:23:22 EST
Notice of Change of Application Due Date and Expiration Date for RFA-HD-16-028 "Non- or Minimally-Invasive Methods to Measure Biochemical Substances during Neonatal and Perinatal Patient Care and Research (R41)"
Notice NOT-HD-15-023 from the NIH Guide for Grants and Contracts
Thu, 02 Jul 2015 11:55:57 EST
Notice of Change to RFA-HL-16-015 "Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes Clinical Research Centers (CRC) (U01)"
Notice NOT-HL-15-264 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 09:25:11 EST
Notice of Change to RFA-HL-16-016 "Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes - Leadership and Data Coordinating Center (LDCC) (U01)"
Notice NOT-HL-15-265 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 09:29:06 EST
Notice of Information: Termination of the Interventions Committee for Adult Disorders (ITVA) and Interventions Committee for Disorders Involving Children and Their Families (ITVC) of the National Institute for Mental Health Initial Review Group (NIMH IRG)
Notice NOT-MH-15-021 from the NIH Guide for Grants and Contracts
Thu, 02 Jul 2015 01:59:38 EST
Notice of Addition of High Throughput Screening to the Scope of PAR-15-070 "IGNITE: Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33)"
Notice NOT-NS-15-031 from the NIH Guide for Grants and Contracts
Thu, 02 Jul 2015 01:54:49 EST
Advance Notice: NIH Anticipates Transition to New Research Training Data Table Formats in FY 2016
Notice NOT-OD-15-112 from the NIH Guide for Grants and Contracts
Mon, 29 Jun 2015 01:28:56 EST
Registration Open for Mobile and Personal Technologies in Precision Medicine Workshop of the Precision Medicine Initiative Working Group of the Advisory Committee to the NIH Director, July 27-28, 2015
Notice NOT-OD-15-115 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 10:38:29 EST
Notice of Corrections PAR-14-228 "NIH Science Education Partnership Award (SEPA) (R25)"
Notice NOT-OD-15-116 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 10:49:44 EST
Notice About Updates to iEdison Regarding Reporting Requirements and Compliance Messages
Notice NOT-OD-15-119 from the NIH Guide for Grants and Contracts
Thu, 02 Jul 2015 01:58:16 EST
NIA Announces Interest in Utilizing the CTSA Network - Trial Innovation Centers (TICs) to Study Alzheimers Disease and Other Aging-related Dementias
Notice NOT-TR-15-016 from the NIH Guide for Grants and Contracts
Tue, 30 Jun 2015 10:53:27 EST
Networks to Develop Priority Areas of Behavioral and Social Research (R24)
Funding Opportunity RFA-AG-16-008 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to provide infrastructure support for advancing development of specific high priority areas of behavioral and social research of relevance to aging.
Wed, 01 Jul 2015 03:16:53 EST
Exploration of the Roles of Brown and Beige Adipose Tissue in Humans (R01)
Funding Opportunity RFA-DK-15-031 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for Research Project Grants (R01) to investigate the biological functions of brown and beige adipose tissue in humans, other than heat production and maintenance of body temperature, and to explore their impact on human health. Specifically, it seeks to 1) identify physiologic or pathophysiologic conditions other than prolonged cold exposure under which browning of human subcutaneous or other white adipose depots occurs, or where the brown adipose tissue depot found in the neck region is expanded through browning; 2) test potential non-biopsy biomarkers of human subcutaneous beige fat and 3) explore the biological functions of human brown and beige fat.
Mon, 29 Jun 2015 01:10:55 EST
Expanding FDA's Produce Safety and Instructor Skills Training under the Food Safety Modernization Act
Funding Opportunity RFA-FD-15-041 from the NIH Guide for Grants and Contracts. The Food and Drug Administration's (FDA), Office of Regulatory Affairs (ORA), Office of Resource Management (ORM), Division of Human Resource Development (DHRD) is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement Grant. The goals of this Cooperative Agreement grant are, one to develop training and related materials/resources for those FDA and State/local regulators under the integrated food safety system (IFSS) that will be conducting produce farm investigations, and inspections under FSMA's new produce safety regulations and the second is to train IFSS regulatory subject matter experts on best practices for adult learning and instructor skills to deliver courses on the new FSMA regulations.
Thu, 02 Jul 2015 02:12:08 EST
Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03)
Funding Opportunity RFA-HL-16-020 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit current or recently completed NHLBI K01, K08, and K23 awardees for grant support to expand their current research objectives or to branch out to a study that resulted from the research conducted under the K award. Recently completed NHLBI K01, K08, and K23 awardees are eligible to apply for this R03 FOA if the earliest possible R03 start date falls within 2 years of their prior NHLBI K award Project Period end date. Thus, this FOA is intended to enhance the capability of NHLBI K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status.
Tue, 30 Jun 2015 08:42:35 EST
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
Funding Opportunity RFA-NS-16-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for the Morris K. Udall Centers of Excellence for Parkinsons Disease Research program. The overarching goal of the specialized Udall Centers program is to establish a network of Centers that work collaboratively as well as independently to define the causes of and discover improved treatments for Parkinsons disease (PD). A more immediate goal for each Center is to rapidly advance synergistic, interdisciplinary research programs while serving as national leaders in PD research. Udall Centers also serve as local resources by organizing research career enhancement activities for Center investigators and periodic outreach to the PD patient/advocacy community. Applicants are expected to identify and address an overall research theme that defines a critical challenge in PD research. The stated theme, proposed research projects, and associated cores will inform the etiology, pathogenesis or treatment of PD; investigations on related synucleinopathies may be included if such studies directly address the identified PD research challenge. Requirements include 1) a minimum of three research projects; 2) research cores that are each essential to accomplish the aims of at least two proposed research projects, plus an Administrative Core; 3) a mission statement and plan for career enhancement of Center researchers; and 4) a plan for outreach to the local patient community. The NINDS Udall Centers program prioritizes innovative and integrative research with significant potential for discovery. A considerable degree of synergy must be evident among Center research projects and cores, such that successful completion of the aims could not be accomplished without the Center structure. The Udall Center Director (PD/PI) must be an established leader in scientific research with visionary leadership skills and proven expertise in the stewardship of large-scale research programs. Eligible institutions must demonstrate commitment to and support for the establishment and/or continuation of the proposed Udall Center. Funding decisions will focus on those applications most likely to make significant contributions to PD research, as well as those with greatest potential to collaborate effectively across the Centers program.
Wed, 01 Jul 2015 12:25:46 EST
Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science (R44)
Funding Opportunity PAR-15-288 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the extended development, maintenance, testing, evaluation, hardening and dissemination of existing biomedical software. This FOA is for applications that have completed the proof of concept Phase I stage-type of research through other (non-SBIR) funding sources. The NIH is interested in promoting a broad base of research and development of a broad base of innovative technologies in biomedical computing, informatics, and Big Data Science that will support rapid progress in areas of scientific opportunity in biomedical research. It is expected that this research and development is conducted in the context of important biomedical and behavioral research problems. As such, applications are intended to develop enabling technologies that could apply to the interests of most NIH Institutes and Centers and range from basic biomedicine to research in all relevant organ systems and diseases. Major themes of research include collaborative environments; data integration; analysis and modeling methodologies; and novel computer science and statistical approaches.New opportunities are also emerging as large and complex data sets are becoming increasingly available to the research community. The proposed work should apply best practices and proven methods for software design, construction, and implementation to extend the applicability of existing technologies in biomedical computing, informatics and big data science to a broader biomedical research community.
Tue, 30 Jun 2015 08:31:53 EST
The Pancreatic Cancer Detection Consortium (U01)
Funding Opportunity PAR-15-289 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions. This initiative addresses one of the four research priorities identified in the National Cancer Institute's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma. The PCDC is intended to support research for the development and testing of new molecular and imaging biomarkers for identifying patients at high risk for PDAC (because of genetic factors or the presence of precursor lesions) who could be candidates for early intervention. The research will be conducted by individual multi-disciplinary research teams, hereafter called Units. The Units will undertake studies on the following areas: identification and testing of biomarkers measurable in bodily fluids for early detection of PDAC or its precursor lesions; determine which pancreatic cysts are likely to progress to cancer; develop molecular- and/or imaging-based approaches for screening populations at high risk of PDAC; conduct biomarker validation studies; and collect longitudinal biospecimens for the establishment of a biorepository. All Units are expected to participate in collaborative activities with other Units and share ideas, specimens and data within the Consortium.
Tue, 30 Jun 2015 09:10:43 EST